Effects of the levonorgestrel-releasing intrauterine system on proliferation and apoptosis in the endometrium

Maruo T, T. Maruo, Takeshi Maruo, Jovelle B. Laoag‐Fernandez, J B Laoag-Fernandez, Laoag-Fernandez JB, P. Pakarinen, H Murakoshi, Homare Murakoshi, Murakoshi H, Spitz IM, I. M. Spitz, Johansson E, E Johansson, Elof D.B. Johansson
Human Reproduction · 2001 · vol. 16(10) , pp. 2103–2108 · doi:10.1093/humrep/16.10.2103 · PMID:11574499 · W2171174006
Other OA: closed CC0 ⤵ 33 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

Levonorgestrel-releasing intrauterine system insertion decreased endometrial proliferation and increased apoptosis in endometrial glands and stroma, associated with altered Fas and Bcl-2 expression.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

BACKGROUND: The levonorgestrel-releasing intrauterine system (LNg-IUS) has been shown to be effective in the management of menorrhagia. In order to evaluate the effects of LNg-IUS on endometrial proliferation and apoptosis, proliferating cell nuclear antigen (PCNA) expression, apoptosis, Fas and Bcl-2 protein expression in the endometrium were determined at the early proliferative phase of the menstrual cycle before and 3 months after LNg-IUS insertion. METHODS: PCNA, Fas and Bcl-2 protein expression were analysed using an avidin-biotin immunoperoxidase method. Apoptosis was assessed by the terminal deoxynucleotidyl transferase-mediated deoxy-UTP nick-end labelling (TUNEL) method. RESULTS: PCNA, immunolocalized both in the nuclei of endometrial glands and stroma was less abundant 3 months after insertion (P < 0.05). Bcl-2 protein, immunolocalized in the cytoplasm of endometrial glands but not in the stroma, became scanty 3 months after insertion. Fas antigen, immunolocalized only in endometrial glands before insertion, became prominent in both endometrial glands and stroma 3 months after insertion. The apoptosis-positive rate of the nuclei in both endometrial glands and stroma was significantly higher 3 months after insertion relative to that before insertion (P < 0.05). CONCLUSIONS: LNg-IUS resulted in a decrease in endometrial proliferation and an increase in apoptosis in endometrial glands and stroma. The increase in apoptosis associated with increased Fas antigen expression and decreased Bcl-2 protein expression in the endometrium may be one of the underlying molecular mechanisms by which LNg-IUS insertion causes the atrophic change of the endometrium.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Apoptosis Endometrium Endometrium Levonorgestrel Adult Adult Apoptosis Apoptosis Cell Division Cell Division Cell Division Drug Delivery Systems Drug Delivery Systems Endometriosis Endometriosis Endometriosis Endometrium Endometrium Endometrium fas Receptor

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (37)

Cited by (30)

Source provenance

europepmc
last seen: 2026-10-11T09:27:45.537177+00:00
openalex
last seen: 2026-05-11T06:16:32.963054+00:00
pubmed
last seen: 2026-10-08T21:00:08.490831+00:00
unpaywall
last seen: 2026-10-11T06:28:45.473802+00:00
License: CC0 · commercial use OK